Andrijes, Regina (2019). The role of tetraspanin 6 in colorectal cancer. University of Birmingham. Ph.D.
|
Andrijes2019PhD.pdf
Text - Accepted Version Available under License All rights reserved. Download (7MB) | Preview |
Abstract
Colorectal cancer is one of the most common cancer types and the second leading cause of cancer-related deaths worldwide. Poor survival of patients highlights the importance of identification of novel prognostic markers. The work in this thesis presents Tspan6 as a potential candidate. Tspan6 is a poorly studied member of the tetraspanin family of proteins that has been implicated in cancer initiation, progression and metastasis. The expression of Tspan6 in a cohort of genetically profiled colorectal adenocarcinomas in this study demonstrated that Tspan6 expression is significantly reduced in tumours vs. adjacent non-cancerous tissues. To illustrate the role of Tspan6 in colorectal cancer (CRC) Tspan6 KO mice carrying APCmin/+ allele were generated. It was found that loss of Tspan6 gene accentuates APC-driven tumorigenesis in vivo. Specifically, these animals developed larger numbers of intestinal and colonic polyps. Interestingly, these polyps were significantly bigger in size and presented with a more severe neoplastic phenotype. The RNAseq analysis of polyps derived from APCmin/+ and APCmin/+Tspan6 KO showed substantial enrichment of differentially expressed genes within the MAPK signalling pathway. Additionally, our experiments with intestinal organoids derived from Tspan6 KO mice and a Caco-2 CRC cell model confirmed the important role of Tspan6 in EGFR-dependent signalling in colonic epithelium via a pathway involving autocrine production of TGF-α. Furthermore, it was demonstrated that Tspan6 regulates the production of EVs through the involvement of an adapter protein syntenin-1, an established partner of Tspan6 which is known to play a critical role in biogenesis of multivesicular bodies (MVBs) and exosomal production. Therefore, it is hypothesised that the Tspan6-syntenin-1 complex plays a critical role in suppressing of colorectal tumorigenesis by controlling autocrine secretion of EGFR ligands via extracellular vesicles. The better understanding of the Tspan6-dependent mechanisms of EGFR regulation can underpin further development of EGFR-targeting therapy and improve survival of CRC patients.
Type of Work: | Thesis (Doctorates > Ph.D.) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Award Type: | Doctorates > Ph.D. | ||||||||||||
Supervisor(s): |
|
||||||||||||
Licence: | All rights reserved | ||||||||||||
College/Faculty: | Colleges (2008 onwards) > College of Medical & Dental Sciences | ||||||||||||
School or Department: | Institute of Cancer and Genomic Sciences | ||||||||||||
Funders: | Medical Research Council | ||||||||||||
Subjects: | Q Science > Q Science (General) R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
||||||||||||
URI: | http://etheses.bham.ac.uk/id/eprint/9145 |
Actions
Request a Correction | |
View Item |
Downloads
Downloads per month over past year